Obesity is associated with a host of health issues including diabetes and heart disease. Often those struggling with obesity rely on various modifications of diet and activity level to treat their condition. However, over the past few years surgical options and medications have become available. Now the Food and Drug Administration (FDA) has approved a new medical device to treat obesity, but it comes with some serious risks.
FDA Approves New Obesity-Treating Medical Device
CBS News reports that the FDA has approved an implant that “curbs the appetite by electrically stimulating stomach nerves.” It is called the Maestro Rechargeable System and it is intended to treat extreme cases of obesity. The implant sends electrical signals to the nerves around the stomach which decreases hunger pangs and makes the patient feel full. The FDA has approved the device for use in adults aged 18 or older who have a body mass index between 35 and 45 and who suffer from at least one obesity-related condition like high blood pressure or diabetes. This is the first obesity-related medical device the FDA has approved since 2007.